Search

everythinglearnresearchcommunity

for

Search:↓

Topical estrogens improved hair growth in about half of the patients.

PUVA treatment led to significant hair regrowth in over half of the patients with alopecia areata totalis and universalis.

Penguin Cold Caps help most patients keep at least half their hair during chemotherapy.

Scalp cooling can help prevent hair loss in about half of chemotherapy patients.

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

Using a microscope during hair transplants cuts damage to follicles in half and could improve hair growth.

Home-use treatment for severe alopecia areata is as effective as office-use but costs half as much.

Post-COVID symptoms are common, affecting over half of the participants.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Melanoma survivors are more likely to use sunscreen and seek shade than others, but less than half often use sunscreen and avoid the sun, and some still use tanning beds.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

Using more minoxidil solution can lead to better hair growth, but people often use only half the recommended amount. Education and motivation can improve results.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Baldness is often hereditary and linked to male hormones, becoming noticeable when half the hair is lost.

Most patients with Tuberous sclerosis had neurological or skin issues, and over half had psychiatric problems.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

Cutting and implanting hair follicles can create finer, more natural-looking hairlines, with about half of the implanted hairs growing back.

Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.

A toddler who accidentally swallowed hair growth medicine experienced serious heart-related side effects but recovered after hospital treatment.

A young boy with a rare skin and nail condition improved significantly with simple topical treatments.

The child was diagnosed with a skin condition involving inflamed hair follicles.

The book provides a historical view of abortion in the U.S., critiques the pro-choice movement, and recommends including abortion in medical education.

Abortion access should be defended on public health grounds, and medical evaluations are crucial in psychiatric cases to avoid misdiagnosis.

Improving scalp health is key to managing dandruff and seborrheic dermatitis.

Both books are valuable resources in their fields.

AIDS may cause changes in the scalp that increase infection risk and hair loss.

Addressing body image and weight can help improve female sexual dysfunction.